Compare DVAX & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVAX | HAS |
|---|---|---|
| Founded | 1996 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 11.1B |
| IPO Year | 2004 | N/A |
| Metric | DVAX | HAS |
|---|---|---|
| Price | $15.40 | $81.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | $26.50 | ★ $88.55 |
| AVG Volume (30 Days) | 1.6M | ★ 1.7M |
| Earning Date | 11-05-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 3.44% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $330,514,000.00 | ★ $4,357,000,000.00 |
| Revenue This Year | $24.63 | $10.26 |
| Revenue Next Year | $15.85 | $6.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 26.73 | 0.79 |
| 52 Week Low | $9.20 | $49.00 |
| 52 Week High | $14.63 | $85.15 |
| Indicator | DVAX | HAS |
|---|---|---|
| Relative Strength Index (RSI) | 89.32 | 54.67 |
| Support Level | $10.78 | $81.00 |
| Resistance Level | $11.29 | $82.51 |
| Average True Range (ATR) | 0.23 | 1.84 |
| MACD | 0.28 | -0.19 |
| Stochastic Oscillator | 97.94 | 38.66 |
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.